Foresite Capital Management Iii, LLC Fibrogen Inc Transaction History

Foresite Capital Management Iii, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $3.11 Million - $8.15 Million	-305,784 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $4.94 Million - $6.53 Million	133,284 Added 77.27%	305,784 $11.3 Million
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $5.36 Million - $6.03 Million	132,500 Added 331.25%	172,500 $7.09 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $932,000 - $1.84 Million	40,000 New	40,000 $1.39 Million
Q3 2017 Nov 13, 2017	SELL	$33.4 - $53.9 $8.35 Million - $13.5 Million	-250,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	250,000	250,000 $8.08 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.